煙草在線據(jù)美聯(lián)社報道編譯　　1月9日版的《神經(jīng)病學(xué)雜志》發(fā)表的一項研究指出，尼古丁貼膏可以幫助患有早期記憶喪失癥的人。范德比爾特大學(xué)醫(yī)學(xué)中心的精神病學(xué)教授Paul Newhouse博士領(lǐng)導(dǎo)開展了一項研究。這項研究顯示，對患有輕度認知損傷——通常是阿爾茨海默病的前兆——的患者使用6個月的尼古丁貼膏進行治療，對于患者這個年齡的人的長期記憶可以有46%的提高。接受不含尼古丁的貼膏治療的患者組的記憶，則下降了26%。兩組患者都接受了6個月的治療。

　　尼古丁只是被稱為生物堿的相關(guān)化合物族中的一個。同族中的另一種混合物新煙草堿，被星科公司積極地探索用于各種用途，包括作為記憶喪失的輔助藥劑。星科公司的子公司Rock Creek制藥公司也有一些正在等待批準的專利，這些專利與給新煙草堿治療神經(jīng)病癥等其他疾病有關(guān)。

Star Scientific: Potential Role of Natural Alkaloids in Combatting Memory Loss

PRNewswire

　　Star Scientific, Inc. (NASDAQ: CIGX) - A study released in the January 9th issue of the Journal of Neurology suggests that nicotine patches may help individuals with early memory loss. Dr. Paul Newhouse, a professor of psychiatry at Vanderbilt University Medical Center, led a study which showed that six months of nicotine patch treatment among patients who had mild cognitive impairment - often a precursor to Alzheimer's disease - had a 46% improvement in their long-term memory for their age. The patient group who received a patch without nicotine showed a 26% decline in memory. Both patient groups were treated for six months.

　　Nicotine is only one of a family of related compounds known as alkaloids. Anatabine, another compound in the same family, has been actively pursued by Star Scientific for a variety of uses, including as a supporter for memory loss. Star Scientific subsidiary Rock Creek Pharmaceuticals also has a number of patents pending that relate to the administration of anatabine for treatment of a variety of neurological conditions, among other things.